Envoy Medical® Corporation recently announced that the FDA has approved its Investigational Device Exemption application to begin a clinical trial with its fully implanted Acclaim® cochlear implant. The single-center Early Feasibility Study for the Acclaim will take place at the Mayo Clinic in Rochester, Minnesota.  

In this week's episode, Brian Taylor sits down with Envoy Medical CEO, Brent Lucas to discuss the company's Acclaim CI and clinical trial.   

Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter: https://www.linkedin.com/company/this-week-in-hearing/ https://twitter.com/WeekinHearing